在老年人中,arachnoid粒度形态与β-amyloid和tau病理有关
medRxiv : the preprint server for health sciences
|November 19, 2025
概括
甲状腺颗粒 (AG) 显示与阿尔茨海默氏症 (AD) 病理学的反向关联. 高水平的β-粉样蛋白和tau结与较少的AG相关,这表明AG形态和AD之间的联系.
科学领域:
- 神经病理学神经病理学
- 衰老研究研究 衰老研究
- 神经退行性疾病 神经退行性疾病
背景情况:
- 桃体颗粒 (AG) 通常会随着年龄的增长而扩大.
- 关于AG在神经退行症中的作用的研究有限.
- 本研究研究了AG形态与阿尔茨海默病 (AD) 病理学的关系.
研究的目的:
- 为了研究状粒度形态与阿尔茨海默氏症神经病理指数之间的关联.
- 了解与年龄相关的AG变化如何与AD病理有关.
主要方法:
- 在882个老年人的死后脑样本中对宏观AG属性的系统评估.
- 使用回归模型来分析AG特征与AD神经病理指数 (β-粉样蛋白,神经纤维状结) 之间的关联.
- 在统计分析中控制人口因素.
主要成果:
- 在β-粉样蛋白水平和全球AG计数 (OR,0.79) 和补丁计数 (OR,0.78) 之间发现了反向关联.
- 观察到神经纤维状结和全球AG计数 (OR,0.84) 之间的反向关联.
- 布拉克得分 (神经纤维质纠阶段) 与全球AG补丁计数 (OR,0.80) 相反相关.
结论:
- 阿尔茨海默病的病理,特别是β-粉样和,与特定的状粒度形态有关.
- 这些发现表明AG特征与AD之间的潜在联系.
- 需要进一步的研究来阐明潜在的机制,并探索疾病阶段和人口统计学方面的差异.
更多相关视频
08:27Establishment of a Valuable Mimic of Alzheimer's Disease in Rat Animal Model by Intracerebroventricular Injection of Composited Amyloid Beta Protein
Published on: July 29, 2018
12.5K
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.1K
相关概念视频
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils
6.3K
6.3K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
